Rivero-Buceta Eva, Carrero Paula, Casanova Elena, Doyagüez Elisa G, Madrona Andrés, Quesada Ernesto, Peréz-Pérez María Jesús, Mateos Raquel, Bravo Laura, Mathys Leen, Noppen Sam, Kiselev Evgeny, Marchand Christophe, Pommier Yves, Liekens Sandra, Balzarini Jan, Camarasa María José, San-Félix Ana
Instituto de Química Médica (IQM-CSIC), Juan de la Cierva 3, 28006 Madrid, Spain.
Instituto de Química Médica (IQM-CSIC), Juan de la Cierva 3, 28006 Madrid, Spain; ABG Patentes, Avenida de Burgos 16D, 28036 Madrid, Spain.
Eur J Med Chem. 2015 Dec 1;106:132-43. doi: 10.1016/j.ejmech.2015.10.027. Epub 2015 Oct 21.
The glycoprotein gp120 of the HIV-1 viral envelope has a high content in mannose residues, particularly α-1,2-mannose oligomers. Compounds that interact with these high-mannose type glycans may disturb the interaction between gp120 and its (co)receptors and are considered potential anti-HIV agents. Previously, we demonstrated that a tripodal receptor (1), with a central scaffold of 1,3,5-triethylbenzene substituted with three 2,3,4-trihydroxybenzoyl groups, selectively recognizes α-1,2-mannose polysaccharides. Here we present additional studies to determine the anti-HIV-1 activity and the mechanism of antiviral activity of this compound. Our studies indicate that 1 shows anti-HIV-1 activity in the low micromolar range and has pronounced gp120 binding and HIV-1 integrase inhibitory capacity. However, gp120 binding rather than integrase inhibition seems to be the primary mechanism of antiviral activity of 1.
HIV-1病毒包膜糖蛋白gp120含有高含量的甘露糖残基,尤其是α-1,2-甘露糖寡聚物。与这些高甘露糖型聚糖相互作用的化合物可能会干扰gp120与其(共)受体之间的相互作用,被认为是潜在的抗HIV药物。此前,我们证明了一种三脚架受体(1),其中心支架为1,3,5-三乙苯,被三个2,3,4-三羟基苯甲酰基取代,可选择性识别α-1,2-甘露糖多糖。在此,我们进行了更多研究以确定该化合物的抗HIV-1活性及抗病毒活性机制。我们的研究表明,1在低微摩尔浓度范围内显示出抗HIV-1活性,并且具有显著的gp120结合能力和HIV-1整合酶抑制能力。然而,gp120结合而非整合酶抑制似乎是1抗病毒活性的主要机制。